Valuation: Amarin Corporation plc

Market Cap 24Cr 21Cr 20Cr 18Cr 34Cr 2.27TCr 34Cr 236.8Cr 93Cr 1.18TCr 90Cr 88Cr 3.78TCr P/E 2026 *
-162x
P/E 2027 * -189x
Enterprise Value 7.68Cr 6.83Cr 6.33Cr 5.76Cr 11Cr 729.2Cr 11Cr 76Cr 30Cr 380.53Cr 29Cr 28Cr 1.21TCr EV / Sales 2026 *
0.43x
EV / Sales 2027 * 0.36x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day-2.16%
1 week-5.90%
Current month-12.92%
1 month-18.21%
3 months-20.17%
6 months-23.10%
Current year-18.88%
1 week 11.25
Extreme 11.25
11.93
1 month 11.25
Extreme 11.25
13.9
Current year 11.25
Extreme 11.25
17.31
1 year 11.25
Extreme 11.25
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
103.2
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 04/06/2024
Director of Finance/CFO 42 23/10/2024
Compliance Officer 56 15/11/2023
Director TitleAgeSince
Director/Board Member 63 04/06/2024
Director/Board Member 43 28/02/2023
Director/Board Member 67 28/02/2023
Date Insider Type Main position Quantity % Market Cap. Importance
01/08/26 Exercice

Chief Financial Officer

781 0.0002%
01/07/26 Exercice

Chief Operating Officer

9,302 0.0022%
01/07/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
-2.16%-5.90%-43.60%-30.10% 24Cr
-6.60%-8.56%+42.79%+64.16% 6.5TCr
-4.09%-0.11%+2.31%+54.81% 5.12TCr
+0.03%+5.56%+10.18%+41.75% 5.12TCr
-1.53%+2.70%+29.72%+34.13% 4.39TCr
-1.34%+4.12%+16.05%+112.18% 4.2TCr
-5.97%-6.22%+258.21%+421.57% 3.81TCr
+6.53%+8.02%+15.74%+53.94% 3.32TCr
-0.90%-10.49%+31.48%-1.63% 2.52TCr
-2.76%-9.54%-16.53%-9.55% 2.2TCr
Average -1.88%-2.09%+34.63%+74.13% 3.72TCr
Weighted average by Cap. -2.30%-1.21%+43.51%+88.50%

Financials

2026 *2027 *
Net sales 18Cr 16Cr 15Cr 13Cr 25Cr 1.68TCr 26Cr 175.73Cr 69Cr 878.82Cr 67Cr 65Cr 2.8TCr 18Cr 16Cr 15Cr 13Cr 25Cr 1.68TCr 25Cr 175.13Cr 69Cr 875.81Cr 66Cr 65Cr 2.79TCr
Net income -2.66Cr -2.37Cr -2.19Cr -2Cr -3.77Cr -252.68Cr -3.83Cr -26Cr -10Cr -131.86Cr -9.99Cr -9.78Cr -420.34Cr -1.83Cr -1.63Cr -1.51Cr -1.37Cr -2.59Cr -173.86Cr -2.63Cr -18Cr -7.11Cr -91Cr -6.88Cr -6.73Cr -289.23Cr
Net Debt -16Cr -14Cr -13Cr -12Cr -23Cr -1.54TCr -23Cr -160.71Cr -63Cr -803.7Cr -61Cr -60Cr -2.56TCr -17Cr -16Cr -14Cr -13Cr -25Cr -1.66TCr -25Cr -173.19Cr -68Cr -866.13Cr -66Cr -64Cr -2.76TCr
Projected Income Statement - Annual - Amarin Corporation plc
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
16/26/16 $11.32 -2.16% 1,13,657
15/26/15 $11.57 -0.34% 54,357
14/26/14 $11.61 +0.26% 51,010
13/26/13 $11.58 +0.43% 1,02,387
12/26/12 $11.53 -4.16% 90,041
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Amarin Corporation plc
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
11.32USD
Average target price
12.50USD
Spread / Average Target
+10.42%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amarin Corporation plc
  1. Stock Market
  2. Stocks
  3. AMRN Stock